semaglutide effect on insulin Mechanism of for management of obesity, NASH, and Benefits of Semaglutide GLP-1 |

Glucagon-like peptide-1 (GLP-1) receptor agonists are gaining popularity as a treatment for Type 2 diabetes and, in some patients, obesity

One patient developed recurrent leukopenia at 1-4 months

These anecdotal reports, whilst not constituting clinical evidence, warrant consideration

Weight loss and breast cancer recurrence Carrying excess weight after a breast cancer diagnosis is associated with worse outcomes

Gastric or bariatric surgery : Patients who have undergone weight loss surgeries such as gastric or bariatric surgery may experience B12 deficiency due to the unavailability of intrinsic factor after gastric or intestinal resection